These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4642946)

  • 1. [Experiences with alpha-tocopherol micotinate in the treatment of arteriosclerosis].
    Dobrowolski L
    Fortschr Med; 1972 Sep; 90(25):913-6. PubMed ID: 4642946
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of tocopherol nicotinate on serum lipids].
    Aigner O; Schlick W
    Int J Clin Pharmacol; 1974 Sep; 10(2):124-8. PubMed ID: 4448553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of the effect of vitamins E, A, nicotinic acid and diet No. 10 on several indices of lipid and protein metabolism in patients with arteriosclerosis].
    Dovgiallo GKh; Kulago GV; Mironchik IF
    Ter Arkh; 1969 Nov; 41(11):34-8. PubMed ID: 5384744
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with -tocopherolnicotinate in arterious peripheral circulation disorders].
    Michael RJ
    Dtsch Med J; 1971 Oct; 22(20):654-6. PubMed ID: 5120336
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of Sadamin, Polfa].
    Lukjan H; Bielawiec M; Bogdanikowa B; Kiersnowska B; Korfel B; Dowzyk W
    Pol Tyg Lek; 1972 May; 27(20):739-40. PubMed ID: 5029663
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic possibilities in blood circulatory and lipid metabolism disorders].
    Schneider H
    Z Allgemeinmed; 1971 Dec; 47(36):1916-8. PubMed ID: 5003958
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic experiences in circulatory disorders of the eye. Results of a multicentric study].
    Illgner P; Marx-Heep I
    Med Welt; 1983 Jan; 34(1):28-30. PubMed ID: 6338341
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)].
    Schimert G
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):389-92. PubMed ID: 4208098
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of arteriosclerosis with nicatol].
    Zharko KP
    Vrach Delo; 1968 Sep; 9():49-52. PubMed ID: 5740305
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
    Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
    Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experimental lipid metabolism studies with essential phospholipids taking into account the arteriosclerosis problem].
    Hammerl H; Pichler O; Studlar M
    Wien Med Wochenschr; 1966 Apr; 116(16):348-52. PubMed ID: 5985190
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of linodoxine treatment on cholesterol and beta-lipoprotein levels in the blood serum of patients with atherosclerosis.
    Modzelewski A; Straczkowski W
    Pol Med J; 1966; 5(6):1221-4. PubMed ID: 5973026
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with new Cosaldon forms].
    Dammann C
    Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of arteriosclerosis with permanently administered large doses of nicotinic acid].
    Hermann B; Tornóczky J
    Z Arztl Fortbild (Jena); 1967 Jan; 61(2):77-81. PubMed ID: 5590807
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of linodoxine treatment on the blood cholesterol and beta-lipoproteid level in arteriosclerotic patients].
    Modzelewski A; Straczkowski W
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1964; 10():30-4. PubMed ID: 4955486
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electroencephalographic study in patients with cerebral arteriosclerotic lesions. Modifications induced by hemokinetic treatment in course of a barbiturate narcosis].
    Ruggerini R; Grugni P; Bolognesi L; Romitti M; Poggi G; Senini G
    Minerva Anestesiol; 1971 Apr; 37(4):164-73. PubMed ID: 5566169
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the use of Nicatol for the treatment of patients with atherosclerosis].
    Kushnir VE
    Vrach Delo; 1967 May; 5():76-9. PubMed ID: 5618549
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical studies on the action of Sadamin Polfa].
    Michal B; Beata B; Beata K; Hieronim L; Ryszard G; Andrzej P; Michal M; Boguslaw K
    Pol Tyg Lek; 1972 May; 27(19):716-8. PubMed ID: 5029660
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Ward NC; Wu JH; Clarke MW; Puddey IB; Burke V; Croft KD; Hodgson JM
    J Hypertens; 2007 Jan; 25(1):227-34. PubMed ID: 17143195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of nicotinic acid on carbohydrate metabolism in diabetics].
    Popper A; Vass A; Elekes A; Firez A
    Med Interna (Bucur); 1965 Oct; 17(10):1241-4. PubMed ID: 5862279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.